The "Contract Research and Manufacturing Services (CRAMS) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Contract Research and ...

NEW YORK, Oct. 7, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The Global Pharmaceutical Contract Research and Manufacturing Market size is estimated to grow by USD 141.3 ...

Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service Expansion Comprehensive CDMO services now featured on ...

NorthStar will provide PDRadiopharma, a wholly-owned subsidiary of PeptiDream, with a broad range of research and development services to support PeptiDream’s internal peptide-RI conjugate programs.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

DUBLIN--(BUSINESS WIRE)--The "Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System ...

Contract development and manufacturing organizations (CDMOs) provide outsourcing options to biotechnology and pharmaceutical companies, helping them advance their drugs from the laboratory to the ...

AGC Biologics has named Tadashi Murano, president of its AGC Life Science Company, as interim CEO while the company searches for a permanent CEO. Murano succeeded Patricio Massera, who stepped down ...

It’s no secret that U.S. biopharma companies rely on Chinese contractors to provide lab research and drug manufacturing services. However, the exact size of this intersection is relatively unclear.

The eight-year, multiple-award-IDIQ contract has a total potential funding value of $149.2M million. ABL, as an awardee of the IDIQ contract pool will provide NINDS current Good Manufacturing ...